NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) — IN8bio Co., Ltd. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T-cell therapies, announced today that CEO and co-founder William Ho will be hosting Noble Capital Markets’ Emerging Market on Thursday, April Announced that he will be speaking at the Growth Virtual Healthcare Equity Conference. 18th 12:30pm ET.
The formal presentation will include a fireside-style Q&A session where questions from the live virtual audience will be welcomed. Attendees interested in watching the live presentation can register for this event here. Register for the Virtual Healthcare Equity Conference.
The IN8bio management team will also host one-on-one meetings with registered and eligible investor attendees during the virtual event. If you are interested, please contact your Noble representative to schedule a meeting.
A video webcast of the presentation will be available on our website after the event. https://investors.in8bio.com/news-events/events-presentationsas part of the complete catalog of presentations available on Channelchek www.channelcheck.com, an investor portal created by Noble. The webcast will be archived on the company’s website and on his Channelchek.com for 90 days after the event ends.
About IN8bio
IN8bio is a clinical-stage biopharmaceutical company developing gamma delta T cell-based immunotherapies for cancer patients. Gamma delta T cells are a specialized T cell population with unique properties, including the ability to distinguish between healthy and diseased tissue. His INB-400, the company’s flagship program, is in Phase 2 trials for glioblastoma multiforme (GBM). Additional programs include Phase 1 trials in solid tumors and hematologic malignancies, including INB-200 for GBM and INB-100 for patients with hematologic malignancies undergoing transplantation. For more information about IN8bio, please visit www.IN8bio.com.
About Noble Capital Markets
Noble Capital Markets (“Noble”) is a research-driven investment bank that has supported small-cap and micro-cap companies since 1984. As a FINRA and SEC licensed broker-dealer, Noble provides institutional quality equity research, merchant and investment banking, and order execution services. In 2005, Noble founded NobleCon, an investor conference that has grown significantly over the past decade.Noble released www.channelcheck.com 2018 – An investor community specializing in listed small and mid-cap stocks and their industries. Channelchek is the first service to offer institutional quality research to the public for free at all levels, without a subscription. The site lists over 6,000 publicly traded emerging growth companies and has a growing list of content including research, webcasts, podcasts, and balanced news.
Corporate contact:
IN8bio Co., Ltd.
Glenn Shulman, PharmD, MPH
203.494.7411
gdschulman@IN8bio.com
Investor
Mel Advisors
Lee M. Stern
lstern@meruadvisors.com
media contact
Kimberly Ha
KKH Advisors
917.291.5744
kimberly.ha@kkhadvisors.com
